CBD works with your dog’s endocannabinoid system, a network of receptors found throughout the body that helps regulate pain, inflammation, anxiety, and immune function. The most robust evidence supports its use for osteoarthritis pain, where a Cornell University study found more than 80% of dogs experienced a measurable decrease in pain. It also shows promise for reducing seizure frequency and easing itchy skin.
How CBD Works in Your Dog’s Body
Dogs have the same two main cannabinoid receptors that humans do: CB1 and CB2. These receptors sit on cells throughout the body, including the brain, gut, skin, blood vessels, and immune cells. They play a role in regulating pain signals, inflammation, anxiety, metabolism, and bone growth.
Unlike THC, CBD doesn’t bind strongly to either receptor. Instead, it influences the endocannabinoid system indirectly, modulating how these receptors respond and how the body processes its own natural cannabinoids. This is why CBD doesn’t produce a “high” but can still affect pain perception, immune responses, and nervous system activity. Dogs have particularly high levels of both CB1 and CB2 receptors on their immune cells, which may help explain why CBD appears to influence inflammation and allergic responses in canines.
Pain and Osteoarthritis Relief
Joint pain is the best-studied use of CBD in dogs. In one of the first clinical trials, conducted at Cornell University, more than 80% of dogs with osteoarthritis showed a decrease in pain after receiving CBD. The dogs became more comfortable and more active, which is exactly what owners of older or arthritic dogs are hoping for.
The doses used in arthritis research are relatively modest: 1 to 2 mg per kilogram of body weight for broad-spectrum CBD products, or 2 mg per kilogram for full-spectrum products that combine CBD with CBDA (a related compound found in raw hemp). For a 30-pound dog, that works out to roughly 14 to 27 mg per dose. CBD reaches its peak concentration in the bloodstream about 1.5 to 2 hours after your dog takes it, and it has a half-life of about 4 hours, meaning the effects taper off within half a day. Most dogs in clinical studies received their dose twice daily.
Seizure Frequency Reduction
CBD has shown encouraging results for dogs with epilepsy. A clinical trial at Colorado State University found that 89% of dogs who received CBD had a reduction in seizure frequency. Other published studies put the reduction more precisely at 25 to 30% fewer seizures with a broad-spectrum CBD product given at 4.5 mg per kilogram twice a day. A full-spectrum CBD/CBDA product given at 2 mg per kilogram twice daily resulted in a 42% reduction in clinically significant seizures.
These numbers are meaningful, but they also mean CBD doesn’t eliminate seizures entirely for most dogs. It’s typically studied alongside conventional seizure medications rather than as a replacement, so it functions more as an add-on therapy that can improve control for dogs whose seizures aren’t fully managed by standard drugs alone.
Itching and Skin Issues
About 65% of dogs in one study responded to a full-spectrum CBD/CBDA product with a clinically significant reduction in itching when given 2 mg per kilogram every 12 hours. This makes sense given that cannabinoid receptors are present in canine skin and that CBD appears to modulate immune cell activity. For dogs dealing with allergic skin conditions or chronic itchiness, this is a less-studied but potentially useful application.
Anxiety and Behavior
Many dog owners turn to CBD for noise phobias (fireworks, thunderstorms) or separation anxiety. This is one of the most popular reasons people buy CBD for their pets, but it’s also where the clinical evidence is thinnest. While the endocannabinoid system clearly plays a role in anxiety regulation, and anecdotal reports from owners are widespread, controlled studies specifically measuring anxiety outcomes in dogs are still limited compared to the pain and seizure research. The biological plausibility is strong, given CB1 receptors in the brain, but the data hasn’t caught up to the marketing claims yet.
Safety and Side Effects
Long-term safety studies suggest CBD is largely safe for dogs at doses up to 10 mg per kilogram per day for as long as 36 weeks. The National Animal Supplement Council reported that 5 mg per kilogram daily was safe for three months of continuous use.
The most consistently noted side effect is an increase in alkaline phosphatase, a liver enzyme, in blood work. This happens because CBD induces certain enzymes in the liver. The elevation itself doesn’t necessarily mean liver damage, but it can complicate the interpretation of routine blood panels. If your dog is on other medications that are processed by the liver, CBD could potentially change how those drugs are metabolized, making their effects stronger or weaker than expected. This is especially relevant for dogs already taking seizure medications or anti-inflammatory drugs.
Other reported side effects tend to be mild: drowsiness, soft stools, or mild gastrointestinal upset. Serious adverse events are rare in published research.
Dosing Basics
Doses in clinical research vary by condition:
- Arthritis pain: 1 to 2 mg per kilogram of body weight, typically twice daily
- Seizures: 2 to 4.5 mg per kilogram, twice daily
- Itching: 2 mg per kilogram, every 12 hours
These are the ranges that produced results in controlled studies. Starting at the lower end and increasing gradually is standard practice, since individual dogs metabolize CBD differently. The type of product matters too: full-spectrum formulas containing both CBD and CBDA have shown stronger results for seizures and itching at lower doses than broad-spectrum CBD alone.
Regulatory Status and Product Quality
CBD products for pets exist in a regulatory gray zone. The FDA has not approved CBD as a food additive for animals and does not consider it Generally Recognized as Safe for use in animal food. As of 2025, the agency continues to issue warning letters to companies selling CBD pet products, stating that adding CBD to animal food is technically illegal under federal law without prior FDA approval.
In practice, CBD pet products are widely sold, but this lack of regulation means quality varies enormously. Products may contain less CBD than labeled, more THC than expected, or contaminants like heavy metals or pesticides. Look for products that provide a certificate of analysis from an independent lab showing the actual cannabinoid content and confirming the absence of contaminants. Products bearing the National Animal Supplement Council (NASC) quality seal have met certain manufacturing and labeling standards, which offers an additional layer of reliability in an otherwise unregulated market.